Neutral
Hear Repligen's CEO give company overview at June 3 webcast
Repligen (NASDAQ: RGEN), a life sciences company, announced that its President and CEO, Olivier Loeillot, will present a company overview at the Willi...
RGEN
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest RGEN News
Neutral
Research RGEN on:
Ad Space